Aspiriant, LLC Eli Lilly & CO Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aspiriant, LLC holds 778 shares of LLY stock, worth $619,031. This represents 0.03% of its overall portfolio holdings.

Number of Shares

778

Previous 3,913 80.12%

Holding current value

$619,031

Previous $3.54 Million 80.55%

% of portfolio

0.03%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$772.14 - $960.02 $2.42 Million - $3.01 Million	-3,135 Reduced 80.12%	778 $689,000
Q2 2024 Jul 15, 2024	BUY	$724.87 - $909.04 $2.32 Million - $2.9 Million	3,195 Added 444.99%	3,913 $3.54 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $5,329 - $7,130	9 Added 1.27%	718 $558,000
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $36,238 - $42,719	69 Added 10.78%	709 $413,000
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $25,647 - $35,358	-59 Reduced 8.44%	640 $343,000
Q2 2023 Jul 19, 2023	BUY	$350.74 - $468.98 $6,664 - $8,910	19 Added 2.79%	699 $327,000
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $8,387 - $9,850	-27 Reduced 3.82%	680 $233,000
Q4 2022 Jan 23, 2023	BUY	$321.55 - $374.67 $227,335 - $264,891	707 New	707 $0
Q3 2021 Oct 27, 2021	SELL	$221.6 - $272.71 $223,594 - $275,164	-1,009 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $182,174 - $235,641	1,009 New	1,009 $232,000
Q4 2020 Feb 01, 2021	SELL	$130.46 - $172.63 $187,210 - $247,724	-1,435 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$146.22 - $169.13 $209,825 - $242,701	1,435 New	1,435 $212,000
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $237,470 - $272,542	-3,137 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$74.21 - $87.6 $232,796 - $274,801	3,137 New	3,137 $243,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account